Macrophage regulation of tumor angiogenesis: Implications for cancer therapy
Tóm tắt
Từ khóa
Tài liệu tham khảo
Adini, 2002, Placental growth factor is a survival factor for tumor endothelial cells and macrophages, Cancer Res, 62, 2749
Ahn, 2008, Matrix metalloproteinase-9 is required for tumor vasculogenesis but not for angiogenesis: role of bone marrow-derived myelomonocytic cells, Cancer Cell, 13, 193, 10.1016/j.ccr.2007.11.032
Ahn, 2010, Inhibition of Mac-1 (CD11b/CD18) enhances tumor response to radiation by reducing myeloid cell recruitment, Proc Natl Acad Sci U S A, 107, 8363, 10.1073/pnas.0911378107
Andreu, 2010, FcRgamma activation regulates inflammation-associated squamous carcinogenesis, Cancer Cell, 17, 121, 10.1016/j.ccr.2009.12.019
Augustin, 2009, Control of vascular morphogenesis and homeostasis through the angiopoietin-Tie system, Nat Rev Mol Cell Biol, 10, 165, 10.1038/nrm2639
Bais, 2010, PlGF blockade does not inhibit angiogenesis during primary tumor growth, Cell, 141, 166, 10.1016/j.cell.2010.01.033
Balkwill, 2001, Inflammation and cancer: back to Virchow?, Lancet, 357, 539, 10.1016/S0140-6736(00)04046-0
Batchelor, 2010, Phase II study of cediranib, an oral pan-vascular endothelial growth factor receptor tyrosine kinase inhibitor, in patients with recurrent glioblastoma, J Clin Oncol, 28, 2817, 10.1200/JCO.2009.26.3988
Beatty, 2011, CD40 agonists alter tumor stroma and show efficacy against pancreatic carcinoma in mice and humans, Science, 331, 1612, 10.1126/science.1198443
Bergers, 2000, Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis, Nat Cell Biol, 2, 737, 10.1038/35036374
Bergers, 2008, Modes of resistance to anti-angiogenic therapy, Nat Rev Cancer, 8, 592, 10.1038/nrc2442
Bertrand, 2005, Three pathways to mature macrophages in the early mouse yolk sac, Blood, 106, 3004, 10.1182/blood-2005-02-0461
Bingle, 2002, The role of tumour-associated macrophages in tumour progression: implications for new anticancer therapies, J Pathol, 196, 254, 10.1002/path.1027
Bingle, 2006, Macrophages promote angiogenesis in human breast tumour spheroids in vivo, Br J Cancer, 94, 101, 10.1038/sj.bjc.6602901
Brown, 2010, A human monoclonal anti-ANG2 antibody leads to broad antitumor activity in combination with VEGF inhibitors and chemotherapy agents in preclinical models, Mol Cancer Ther, 9, 145, 10.1158/1535-7163.MCT-09-0554
Carmeliet, 1999, Impaired myocardial angiogenesis and ischemic cardiomyopathy in mice lacking the vascular endothelial growth factor isoforms VEGF164 and VEGF188, Nat Med, 5, 495, 10.1038/8379
Casanovas, 2005, Drug resistance by evasion of antiangiogenic targeting of VEGF signaling in late-stage pancreatic islet tumors, Cancer Cell, 8, 299, 10.1016/j.ccr.2005.09.005
Casazza, 2011, Systemic and Targeted Delivery of Semaphorin 3A Inhibits Tumor Angiogenesis and Progression in Mouse Tumor Models, Arterioscler Thromb Vasc Biol, 31, 741, 10.1161/ATVBAHA.110.211920
Castro-Rivera, 2004, Semaphorin 3B (SEMA3B) induces apoptosis in lung and breast cancer, whereas VEGF165 antagonizes this effect, Proc Natl Acad Sci U S A, 101, 11432, 10.1073/pnas.0403969101
Ceradini, 2004, Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1, Nat Med, 10, 858, 10.1038/nm1075
Chan, 2009, Tumor vasculature is regulated by PHD2-mediated angiogenesis and bone marrow-derived cell recruitment, Cancer Cell, 15, 527, 10.1016/j.ccr.2009.04.010
Chen, 2005, Tumor-associated macrophages: the double-edged sword in cancer progression, J Clin Oncol, 23, 953, 10.1200/JCO.2005.12.172
Chinetti-Gbaguidi, 2011, Human Atherosclerotic Plaque Alternative Macrophages Display Low Cholesterol Handling but High Phagocytosis Because of Distinct Activities of the PPAR{gamma} and LXR{alpha} Pathways, Circ Res, 108, 985, 10.1161/CIRCRESAHA.110.233775
Coffelt, S.B., Chen, Y.Y., Muthana, M., Welford, A.F., Tal, A.O., Scholz, A., Plate, K.H., Reiss, Y., Murdoch, C., De Palma, M., Lewis, C.E., 2011. Angiopoietin 2 Stimulates TIE2-Expressing Monocytes To Suppress T Cell Activation and To Promote Regulatory T Cell Expansion. J Immunol.
Coffelt, 2010, Elusive identities and overlapping phenotypes of proangiogenic myeloid cells in tumors, Am J Pathol, 176, 1564, 10.2353/ajpath.2010.090786
Coffelt, 2010, Angiopoietin-2 regulates gene expression in TIE2-expressing monocytes and augments their inherent proangiogenic functions, Cancer Res, 70, 5270, 10.1158/0008-5472.CAN-10-0012
Conrotto, 2005, Sema4D induces angiogenesis through Met recruitment by Plexin B1, Blood, 105, 4321, 10.1182/blood-2004-07-2885
Coussens, 2000, MMP-9 supplied by bone marrow-derived cells contributes to skin carcinogenesis, Cell, 103, 481, 10.1016/S0092-8674(00)00139-2
Cramer, 2003, HIF-1alpha is essential for myeloid cell-mediated inflammation, Cell, 112, 645, 10.1016/S0092-8674(03)00154-5
Daley, 2008, Use of Ly6G-specific monoclonal antibody to deplete neutrophils in mice, J Leukoc Biol, 83, 64, 10.1189/jlb.0407247
Dannenberg, 2003, Targeting cyclooxygenase-2 in human neoplasia: rationale and promise, Cancer Cell, 4, 431, 10.1016/S1535-6108(03)00310-6
Dawson, 2009, VEGFR1-activity-independent metastasis formation, Nature, 461, E4, 10.1038/nature08254
De Palma, 2008, Tumor-targeted interferon-alpha delivery by Tie2-expressing monocytes inhibits tumor growth and metastasis, Cancer Cell, 14, 299, 10.1016/j.ccr.2008.09.004
De Palma, 2005, Tie2 identifies a hematopoietic lineage of proangiogenic monocytes required for tumor vessel formation and a mesenchymal population of pericyte progenitors, Cancer Cell, 8, 211, 10.1016/j.ccr.2005.08.002
De Palma, 2003, Targeting exogenous genes to tumor angiogenesis by transplantation of genetically modified hematopoietic stem cells, Nat Med, 9, 789, 10.1038/nm871
de Visser, 2006, Paradoxical roles of the immune system during cancer development, Nat Rev Cancer, 6, 24, 10.1038/nrc1782
DeNardo, D.G., Brennan, D.J., Rexhepaj, E., Ruffell, B., Shiao, S.L, Madden, S.F., Gallagher, W.M., Wadhwani, N., Keil, S.D., Junaid, S.A., Rugo, H.S., Hwang, E.S., Jirström, K., West, B.L., Coussens, L.M. Leukocyte complexity predicts breast cancer survival and functionality regulates response tochemotherapy. Cancer Discovery, in press. doi:10.1158/2159-8274.CD-10-0028.
Deonarine, 2007, Gene expression profiling of cutaneous wound healing, J Transl Med, 5, 11, 10.1186/1479-5876-5-11
Du, 2008, HIF1alpha induces the recruitment of bone marrow-derived vascular modulatory cells to regulate tumor angiogenesis and invasion, Cancer Cell, 13, 206, 10.1016/j.ccr.2008.01.034
Ebos, 2009, Accelerated metastasis after short-term treatment with a potent inhibitor of tumor angiogenesis, Cancer Cell, 15, 232, 10.1016/j.ccr.2009.01.021
Egeblad, 2008, Visualizing stromal cell dynamics in different tumor microenvironments by spinning disk confocal microscopy, Dis Model Mech, 1, 155, 10.1242/dmm.000596
Egeblad, 2010, Tumors as organs: complex tissues that interface with the entire organism, Dev Cell, 18, 884, 10.1016/j.devcel.2010.05.012
Fang, 2009, Hypoxia-inducible factors 1 and 2 are important transcriptional effectors in primary macrophages experiencing hypoxia, Blood, 114, 844, 10.1182/blood-2008-12-195941
Fantin, 2010, Tissue macrophages act as cellular chaperones for vascular anastomosis downstream of VEGF-mediated endothelial tip cell induction, Blood, 116, 829, 10.1182/blood-2009-12-257832
Fiedler, 2006, Angiopoietin-2 sensitizes endothelial cells to TNF-alpha and has a crucial role in the induction of inflammation, Nat Med, 12, 235, 10.1038/nm1351
Finch, 2004, Inflammatory exposure and historical changes in human life-spans, Science, 305, 1736, 10.1126/science.1092556
Fischer, 2007, Anti-PlGF inhibits growth of VEGF(R)-inhibitor-resistant tumors without affecting healthy vessels, Cell, 131, 463, 10.1016/j.cell.2007.08.038
Fischer, 2008, FLT1 and its ligands VEGFB and PlGF: drug targets for anti-angiogenic therapy?, Nat Rev Cancer, 8, 942, 10.1038/nrc2524
Gabrilovich, 2009, Myeloid-derived suppressor cells as regulators of the immune system, Nat Rev Immunol, 9, 162, 10.1038/nri2506
Garcia-Barros, 2003, Tumor response to radiotherapy regulated by endothelial cell apoptosis, Science, 300, 1155, 10.1126/science.1082504
Gaur, 2009, Role of class 3 semaphorins and their receptors in tumor growth and angiogenesis, Clin Cancer Res, 15, 6763, 10.1158/1078-0432.CCR-09-1810
Geissmann, 2008, Blood monocytes: distinct subsets, how they relate to dendritic cells, and their possible roles in the regulation of T-cell responses, Immunol Cell Biol, 86, 398, 10.1038/icb.2008.19
Gierach, 2008, Nonsteroidal anti-inflammatory drugs and breast cancer risk in the National Institutes of Health-AARP Diet and Health Study, Breast Cancer Res, 10, R38, 10.1186/bcr2089
Giraudo, 2004, An amino-bisphosphonate targets MMP-9-expressing macrophages and angiogenesis to impair cervical carcinogenesis, J Clin Invest, 114, 623, 10.1172/JCI200422087
Gordon, 2010, Alternative activation of macrophages: mechanism and functions, Immunity, 32, 593, 10.1016/j.immuni.2010.05.007
Grunewald, 2006, VEGF-induced adult neovascularization: recruitment, retention, and role of accessory cells, Cell, 124, 175, 10.1016/j.cell.2005.10.036
Guleng, 2005, Blockade of the stromal cell-derived factor-1/CXCR4 axis attenuates in vivo tumor growth by inhibiting angiogenesis in a vascular endothelial growth factor-independent manner, Cancer Res, 65, 5864, 10.1158/0008-5472.CAN-04-3833
Hagemann, 2008, “Re-educating” tumor-associated macrophages by targeting NF-kappaB, J Exp Med, 205, 1261, 10.1084/jem.20080108
Hagemann, 2006, Ovarian cancer cells polarize macrophages toward a tumor-associated phenotype, J Immunol, 176, 5023, 10.4049/jimmunol.176.8.5023
Hawighorst, 2002, Activation of the tie2 receptor by angiopoietin-1 enhances tumor vessel maturation and impairs squamous cell carcinoma growth, Am J Pathol, 160, 1381, 10.1016/S0002-9440(10)62565-5
Holash, 1999, Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF, Science, 284, 1994, 10.1126/science.284.5422.1994
Horsman, 2011, Vascular targeting therapy: potential benefit depends on tumor and host related effects, Exp Oncol, 32, 143
Huang, 2011, Specifically targeting angiopoietin-2 inhibits angiogenesis, tie2-expressing monocyte infiltration, and tumor growth, Clin Cancer Res, 17, 1001, 10.1158/1078-0432.CCR-10-2317
Imtiyaz, 2010, Hypoxia-inducible factor 2alpha regulates macrophage function in mouse models of acute and tumor inflammation, The Journal of Clinical Investigation, 120, 2699, 10.1172/JCI39506
Jain, 2005, Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy, Science, 307, 58, 10.1126/science.1104819
Jeon, 2003, Tie-ing the antiinflammatory effect of angiopoietin-1 to inhibition of NF-kappaB, Circ Res, 92, 586, 10.1161/01.RES.0000066881.04116.45
Kim, 2008, High tumour islet macrophage infiltration correlates with improved patient survival but not with EGFR mutations, gene copy number or protein expression in resected non-small cell lung cancer, Br J Cancer, 98, 1118, 10.1038/sj.bjc.6604256
Kioi, 2010, Inhibition of vasculogenesis, but not angiogenesis, prevents the recurrence of glioblastoma after irradiation in mice, J Clin Invest, 120, 694, 10.1172/JCI40283
Kozin, 2010, Recruitment of myeloid but not endothelial precursor cells facilitates tumor regrowth after local irradiation, Cancer Res, 70, 5679, 10.1158/0008-5472.CAN-09-4446
Lee, 2002, Mannose receptor-mediated regulation of serum glycoprotein homeostasis, Science, 295, 1898, 10.1126/science.1069540
Leek, 1996, Association of macrophage infiltration with angiogenesis and prognosis in invasive breast carcinoma, Cancer Res, 56, 4625
Leek, 2002, Relation of hypoxia-inducible factor-2 alpha (HIF-2 alpha) expression in tumor-infiltrative macrophages to tumor angiogenesis and the oxidative thymidine phosphorylase pathway in Human breast cancer, Cancer Research, 62, 1326
Lewis, 2006, Distinct role of macrophages in different tumor microenvironments, Cancer Res, 66, 605, 10.1158/0008-5472.CAN-05-4005
Lewis, 2000, Expression of vascular endothelial growth factor by macrophages is up-regulated in poorly vascularized areas of breast carcinomas, J Pathol, 192, 150, 10.1002/1096-9896(2000)9999:9999<::AID-PATH687>3.0.CO;2-G
Lin, 2006, Macrophages regulate the angiogenic switch in a mouse model of breast cancer, Cancer Res, 66, 11238, 10.1158/0008-5472.CAN-06-1278
Lin, 2001, Colony-stimulating factor 1 promotes progression of mammary tumors to malignancy, J Exp Med, 193, 727, 10.1084/jem.193.6.727
Lin, 2007, Tumor-associated macrophages press the angiogenic switch in breast cancer, Cancer Res, 67, 5064, 10.1158/0008-5472.CAN-07-0912
Loberg, 2007, CCL2 as an important mediator of prostate cancer growth in vivo through the regulation of macrophage infiltration, Neoplasia, 9, 556, 10.1593/neo.07307
Lobov, 2005, WNT7b mediates macrophage-induced programmed cell death in patterning of the vasculature, Nature, 437, 417, 10.1038/nature03928
Lyden, 2001, Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth, Nat Med, 7, 1194, 10.1038/nm1101-1194
Lyden, 1999, Id1 and Id3 are required for neurogenesis, angiogenesis and vascularization of tumour xenografts, Nature, 401, 670, 10.1038/44334
MacDonald, 2010, An antibody against the colony-stimulating factor 1 receptor depletes the resident subset of monocytes and tissue- and tumor-associated macrophages but does not inhibit inflammation, Blood, 116, 3955, 10.1182/blood-2010-02-266296
Maisonpierre, 1997, Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis, Science, 277, 55, 10.1126/science.277.5322.55
Mantovani, 2002, Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes, Trends Immunol, 23, 549, 10.1016/S1471-4906(02)02302-5
Mazzieri, 2011, Targeting the ANG2/TIE2 Axis Inhibits Tumor Growth and Metastasis by Impairing Angiogenesis and Disabling Rebounds of Proangiogenic Myeloid Cells, Cancer Cell, 19, 512, 10.1016/j.ccr.2011.02.005
Mills, 2000, M-1/M-2 macrophages and the Th1/Th2 paradigm, J Immunol, 164, 6166, 10.4049/jimmunol.164.12.6166
Moldovan, 2000, Contribution of monocytes/macrophages to compensatory neovascularization: the drilling of metalloelastase-positive tunnels in ischemic myocardium, Circ Res, 87, 378, 10.1161/01.RES.87.5.378
Movahedi, 2008, Identification of discrete tumor-induced myeloid-derived suppressor cell subpopulations with distinct T cell-suppressive activity, Blood, 111, 4233, 10.1182/blood-2007-07-099226
Movahedi, 2010, Different tumor microenvironments contain functionally distinct subsets of macrophages derived from Ly6C(high) monocytes, Cancer Res, 70, 5728, 10.1158/0008-5472.CAN-09-4672
Muramatsu, 2010, Vascular endothelial growth factor receptor-1 signaling promotes mobilization of macrophage lineage cells from bone marrow and stimulates solid tumor growth, Cancer Res, 70, 8211, 10.1158/0008-5472.CAN-10-0202
Murdoch, 2004, Mechanisms regulating the recruitment of macrophages into hypoxic areas of tumors and other ischemic tissues, Blood, 104, 2224, 10.1182/blood-2004-03-1109
Murdoch, 2008, The role of myeloid cells in the promotion of tumour angiogenesis, Nat Rev Cancer, 8, 618, 10.1038/nrc2444
Murdoch, 2007, Expression of Tie-2 by human monocytes and their responses to angiopoietin-2, J Immunol, 178, 7405, 10.4049/jimmunol.178.11.7405
Nakayama, 2002, Relationships between tumor-associated macrophages and clinicopathological factors in patients with colorectal cancer, Anticancer Res, 22, 4291
Nam, 2007, Dysadherin: a new player in cancer progression, Cancer Lett, 255, 161, 10.1016/j.canlet.2007.02.018
Nasarre, 2009, Host-derived angiopoietin-2 affects early stages of tumor development and vessel maturation but is dispensable for later stages of tumor growth, Cancer Res, 69, 1324, 10.1158/0008-5472.CAN-08-3030
Neufeld, 2008, The semaphorins: versatile regulators of tumour progression and tumour angiogenesis, Nat Rev Cancer, 8, 632, 10.1038/nrc2404
Nozawa, 2006, Infiltrating neutrophils mediate the initial angiogenic switch in a mouse model of multistage carcinogenesis, Proc Natl Acad Sci U S A, 103, 12493, 10.1073/pnas.0601807103
Ojalvo, 2009, High-density gene expression analysis of tumor-associated macrophages from mouse mammary tumors, Am J Pathol, 174, 1048, 10.2353/ajpath.2009.080676
Orimo, 2005, Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion, Cell, 121, 335, 10.1016/j.cell.2005.02.034
Orlikowsky, 1999, Activation or destruction of T cells via macrophages, Pathobiology, 67, 298, 10.1159/000028084
Ostrand-Rosenberg, 2009, Myeloid-derived suppressor cells: linking inflammation and cancer, J Immunol, 182, 4499, 10.4049/jimmunol.0802740
Paez-Ribes, 2009, Antiangiogenic therapy elicits malignant progression of tumors to increased local invasion and distant metastasis, Cancer Cell, 15, 220, 10.1016/j.ccr.2009.01.027
Pahler, 2008, Plasticity in tumor-promoting inflammation: impairment of macrophage recruitment evokes a compensatory neutrophil response, Neoplasia, 10, 329, 10.1593/neo.07871
Peranzoni, 2010, Myeloid-derived suppressor cell heterogeneity and subset definition, Curr Opin Immunol, 22, 238, 10.1016/j.coi.2010.01.021
Pollard, 2009, Trophic macrophages in development and disease, Nat Rev Immunol, 9, 259, 10.1038/nri2528
Polverini, 1977, Activated macrophages induce vascular proliferation, Nature, 269, 804, 10.1038/269804a0
Pucci, 2009, A distinguishing gene signature shared by tumor-infiltrating Tie2-expressing monocytes, blood “resident” monocytes, and embryonic macrophages suggests common functions and developmental relationships, Blood, 114, 901, 10.1182/blood-2009-01-200931
Puig-Kroger, 2009, Folate receptor beta is expressed by tumor-associated macrophages and constitutes a marker for M2 anti-inflammatory/regulatory macrophages, Cancer Res, 69, 9395, 10.1158/0008-5472.CAN-09-2050
Purhonen, 2008, Bone marrow-derived circulating endothelial precursors do not contribute to vascular endothelium and are not needed for tumor growth, Proc Natl Acad Sci U S A, 105, 6620, 10.1073/pnas.0710516105
Qian, 2009, A distinct macrophage population mediates metastatic breast cancer cell extravasation, establishment and growth, PLoS One, 4, e6562, 10.1371/journal.pone.0006562
Qian, 2010, Macrophage diversity enhances tumor progression and metastasis, Cell, 141, 39, 10.1016/j.cell.2010.03.014
Rahme, 2003, The cyclooxygenase-2-selective inhibitors rofecoxib and celecoxib prevent colorectal neoplasia occurrence and recurrence, Gastroenterology, 125, 404, 10.1016/S0016-5085(03)00880-1
Rolny, 2008, The tumor suppressor semaphorin 3B triggers a prometastatic program mediated by interleukin 8 and the tumor microenvironment, J Exp Med, 205, 1155, 10.1084/jem.20072509
Rolny, 2011, HRG inhibits tumor growth and metastasis by inducing macrophage polarization and vessel normalization through downregulation of PlGF, Cancer Cell, 19, 31, 10.1016/j.ccr.2010.11.009
Ryder, 2008, Increased density of tumor-associated macrophages is associated with decreased survival in advanced thyroid cancer, Endocr Relat Cancer, 15, 1069, 10.1677/ERC-08-0036
Saharinen, 2008, Angiopoietins assemble distinct Tie2 signalling complexes in endothelial cell-cell and cell-matrix contacts, Nat Cell Biol, 10, 527, 10.1038/ncb1715
Saji, 2001, Significant correlation of monocyte chemoattractant protein-1 expression with neovascularization and progression of breast carcinoma, Cancer, 92, 1085, 10.1002/1097-0142(20010901)92:5<1085::AID-CNCR1424>3.0.CO;2-K
Salcedo, 2000, Human endothelial cells express CCR2 and respond to MCP-1: direct role of MCP-1 in angiogenesis and tumor progression, Blood, 96, 34, 10.1182/blood.V96.1.34
Sanchez-Martin, 2010, The chemokine CXCL12 regulates monocyte-macrophage differentiation and RUNX3 expression, Blood, 117, 88, 10.1182/blood-2009-12-258186
Sangaletti, 2010, Oncogene-driven intrinsic inflammation induces leukocyte production of tumor necrosis factor that critically contributes to mammary carcinogenesis, Cancer Res, 70, 7764, 10.1158/0008-5472.CAN-10-0471
Seegar, 2010, Tie1-Tie2 interactions mediate functional differences between angiopoietin ligands, Mol Cell, 37, 643, 10.1016/j.molcel.2010.02.007
Serbina, 2006, Monocyte emigration from bone marrow during bacterial infection requires signals mediated by chemokine receptor CCR2, Nat Immunol, 7, 311, 10.1038/ni1309
Shaked, 2006, Therapy-induced acute recruitment of circulating endothelial progenitor cells to tumors, Science, 313, 1785, 10.1126/science.1127592
Shaked, 2008, Rapid chemotherapy-induced acute endothelial progenitor cell mobilization: implications for antiangiogenic drugs as chemosensitizing agents, Cancer Cell, 14, 263, 10.1016/j.ccr.2008.08.001
Shiao, 2010, The tumor-immune microenvironment and response to radiation therapy, J Mammary Gland Biol Neoplasia, 15, 411, 10.1007/s10911-010-9194-9
Shojaei, 2008, Refractoriness to antivascular endothelial growth factor treatment: role of myeloid cells, Cancer Res, 68, 5501, 10.1158/0008-5472.CAN-08-0925
Shojaei, 2007, Tumor refractoriness to anti-VEGF treatment is mediated by CD11b+Gr1+ myeloid cells, Nat Biotechnol, 25, 911, 10.1038/nbt1323
Shojaei, 2007, Bv8 regulates myeloid-cell-dependent tumour angiogenesis, Nature, 450, 825, 10.1038/nature06348
Sica, 2007, Altered macrophage differentiation and immune dysfunction in tumor development, J Clin Invest, 117, 1155, 10.1172/JCI31422
Sidky, 1975, Lymphocyte-induced angiogenesis: a quantitative and sensitive assay of the graft-vs.-host reaction, J Exp Med, 141, 1084, 10.1084/jem.141.5.1084
Sierra, 2008, Tumor angiogenesis and progression are enhanced by Sema4D produced by tumor-associated macrophages, J Exp Med, 205, 1673, 10.1084/jem.20072602
Steidl, 2011, Macrophages predict treatment outcome in Hodgkin’s lymphoma, Haematologica, 96, 186, 10.3324/haematol.2010.033316
Steidl, 2010, Tumor-associated macrophages and survival in classic Hodgkin’s lymphoma, N Engl J Med, 362, 875, 10.1056/NEJMoa0905680
Stein, 1992, Interleukin 4 potently enhances murine macrophage mannose receptor activity: a marker of alternative immunologic macrophage activation, J Exp Med, 176, 287, 10.1084/jem.176.1.287
Stockmann, 2008, Deletion of vascular endothelial growth factor in myeloid cells accelerates tumorigenesis, Nature, 456, 814, 10.1038/nature07445
Suri, 1996, Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis, Cell, 87, 1171, 10.1016/S0092-8674(00)81813-9
Suzuki, 2008, Semaphorins and their receptors in immune cell interactions, Nat Immunol, 9, 17, 10.1038/ni1553
Szlosarek, 2003, Tumour necrosis factor alpha: a potential target for the therapy of solid tumours, Lancet Oncol, 4, 565, 10.1016/S1470-2045(03)01196-3
Takakura, 1998, Critical role of the TIE2 endothelial cell receptor in the development of definitive hematopoiesis, Immunity, 9, 677, 10.1016/S1074-7613(00)80665-2
Talks, 2000, The expression and distribution of the hypoxia-inducible factors HIF-1alpha and HIF-2alpha in normal human tissues, cancers, and tumor-associated macrophages, The American journal of pathology, 157, 411, 10.1016/S0002-9440(10)64554-3
Thomas, 2010, Angiopoietin-2 stimulation of endothelial cells induces alphavbeta3 integrin internalization and degradation, J Biol Chem, 285, 23842, 10.1074/jbc.M109.097543
Tomizawa, 2001, Inhibition of lung cancer cell growth and induction of apoptosis after reexpression of 3p21.3 candidate tumor suppressor gene SEMA3B, Proc Natl Acad Sci U S A, 98, 13954, 10.1073/pnas.231490898
Tozer, 1999, Combretastatin A-4 phosphate as a tumor vascular-targeting agent: early effects in tumors and normal tissues, Cancer Res, 59, 1626
Ueno, 2000, Significance of macrophage chemoattractant protein-1 in macrophage recruitment, angiogenesis, and survival in human breast cancer, Clin Cancer Res, 6, 3282
Vakkila, 2004, Inflammation and necrosis promote tumour growth, Nat Rev Immunol, 4, 641, 10.1038/nri1415
Varshavsky, 2008, Semaphorin-3B is an angiogenesis inhibitor that is inactivated by furin-like pro-protein convertases, Cancer Res, 68, 6922, 10.1158/0008-5472.CAN-07-5408
Venneri, 2007, Identification of proangiogenic TIE2-expressing monocytes (TEMs) in human peripheral blood and cancer, Blood, 109, 5276, 10.1182/blood-2006-10-053504
Wang, 2006, Enhanced expression of Duffy antigen receptor for chemokines by breast cancer cells attenuates growth and metastasis potential, Oncogene, 25, 7201, 10.1038/sj.onc.1209703
Welford, 2011, TIE2-expressing macrophages limit the therapeutic efficacy of the vascular-disrupting agent combretastatin A4 phosphate in mice, J Clin Invest, 121, 1969, 10.1172/JCI44562
Wyckoff, 2007, Direct visualization of macrophage-assisted tumor cell intravasation in mammary tumors, Cancer Res, 67, 2649, 10.1158/0008-5472.CAN-06-1823
Youn, 2008, Subsets of myeloid-derived suppressor cells in tumor-bearing mice, J Immunol, 181, 5791, 10.4049/jimmunol.181.8.5791
Zeisberger, 2006, Clodronate-liposome-mediated depletion of tumour-associated macrophages: a new and highly effective antiangiogenic therapy approach, Br J Cancer, 95, 272, 10.1038/sj.bjc.6603240
Zhang, 2010, Multiple roles of chemokine (C-C motif) ligand 2 in promoting prostate cancer growth, J Natl Cancer Inst, 102, 522, 10.1093/jnci/djq044
Zhou, 2009, Increased intratumoral regulatory T cells are related to intratumoral macrophages and poor prognosis in hepatocellular carcinoma patients, Int J Cancer, 125, 1640, 10.1002/ijc.24556